Zachary Newman, Ph.D.

Patent Agent, Intellectual Property  

San Francisco 415.875.2271


Zachary (Zach) Newman assists in the drafting of U.S. and foreign patent applications for clients in the technology and life sciences industries, with technical expertise in the fields of molecular biology and immunology.

Prior to joining Fenwick, Zach’s experience in the academic setting exposed him to a variety of cutting-edge technologies used to explore complex biological questions, primarily in the area of immunology. While in graduate school at UC Berkeley, Zach performed research in the lab of Greg Barton exploring novel regulatory mechanisms of the innate immune system with a focus on mechanisms that prevent autoimmune diseases such as lupus. His research took advantage of the wide range of state-of-the-art tools available at Berkeley, including CRISPR and ribosome-profiling.

Prior to graduate school, Zach investigated the biology of tuberculosis as a research technician in the lab of Jeff Cox at UCSF, and also explored i​mprovements of HIV therapies as an intern in the lab of John Rossi at City of Hope Beckmann Research Institute.


  • Newman ZR, Young JM, Ingolia NT, Barton GM. Differences in GC content and codon bias contribute to the balanced expression of TLR7 and TLR9. Proc Natl Acad Sci. 2016 Mar 8;113(10):E1362-71
  • Deguine J, Lee BL, Newman ZR, Barton GM. (2013) No antigen-presentation defect in Unc93b1(3d/3d) (3d) mice. Nature Immunology. 2013 Nov;14(11):1101-2.
  • Lee BL, Moon JE, Shu JH, Yuan L, Newman ZR, Schekman R, Barton GM. (2013) UNC93B1 mediates differential traffic​king of endosomal TLRs. eLife. 2013;2:e00291.